Skip to main content
. 2022 Apr 6;14(4):797. doi: 10.3390/pharmaceutics14040797

Figure 2.

Figure 2

Schematic illustration of receptor-mediated BBB (A) and BBTB (B) penetration, and receptor-mediated endocytosis and subsequent intracellular drug release (C) enabled by active tumor-targeted drug NCs in vivo. BBB, blood-brain barrier; BBTB, blood-brain tumor barrier; NCs, nanocrystals.